BCL2 and head and neck cancer: MSNs with curcumin (Cur-MSNs) have previously shown selective cytotoxicity against HN5 head and neck cancer cells by lowering Bcl-2 expression, increasing the Bax/Bcl-2 ratio, and inducing ROS-mediated apoptosis (Sharifi et al., 2022).